sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Home / All latest News / Global Hemoglobinopathies Market

Global Hemoglobinopathies Market Projected to Reach USD 13,465.2 Million by 2026

19-May-2020 | Facts and Factors

Findings from Facts and Factors report “Hemoglobinopathies Market by Indication (Sickle cell disease, Alpha Thalassemia, Beta Thalassemia and Others), Therapy (Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, and Others), Diagnosis (Blood testing, Genetic testing, Pre-implantation Genetic Diagnosis (PGD) and Other), and end-user (Hospitals, Diagnostic Laboratories, Clinics, and Other End-user): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Hemoglobinopathies market in 2019 was approximately USD 5,423.5 Million. The market is expected to grow above a CAGR of 10.34% and is anticipated to reach over USD 13,465.2 Million by 2026.

Hemoglobinopathies are caused by defects in the genes and by anemia. Default hemoglobin formation is observed in three conditions, such as hemoglobin molecule structural defects, reduced production of one of the two hemoglobin molecule subunits, and abnormal interactions of otherwise safe subunits. There can be serious or mild illnesses. Genetic diagnosis, genetic and blood testing, electrophoresis of alkaline and acid gel, hemoglobin electrophoresis, genetic prenatal testing, and chromatography exchange of ions HbA2 are the most common tools/tests for diagnosis of hemoglobinopathy and thalassemia.

Request Sample Request Customization Buy Now

Improved R&D investments are projected to contribute to demand development for new therapies. The National Heart, Lung, and Blood Institute (NHLBI), part of the National Health Institutes (NIH), is funding SCD research programs to find new methods of identifying and managing the disease and enhancing patient outcomes. New techniques are being developed using advances in gene-editing technology to modify or delete the faulty sickle cell disease gene and carry the restored gene back to the patients. Through support for sickle cell disease prevention and care through legislation such as the Sickle Cell Disease Research, Surveillance, Prevention, and Care Act, 2018 is also likely to lead to better management of the situation.

Browse the full “Hemoglobinopathies Market by Indication (Sickle cell disease, Alpha Thalassemia, Beta Thalassemia and Others), Therapy (Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, and Others), Diagnosis (Blood testing, Genetic testing, Pre-implantation Genetic Diagnosis (PGD) and Other), and end-user (Hospitals, Diagnostic Laboratories, Clinics, and Other End-user): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/hemoglobinopathies-market-by-indication-sickle-cell-disease-alpha

The Hemoglobinopathies market is segmented into indication, therapy, diagnosis, end-user and region segment. The indication segment is segmented into sickle cell disease, alpha-thalassemia, beta-thalassemia, and others. The therapy segment is divided into iron chelation therapy, blood transfusion, bone marrow transplant, and others. In 2018, blood transfusion therapy held the largest market share. Rising policy measures to increase the number of blood donors are a high impact making engine for the demand for hemoglobinopathies. The Diagnosis segment is bifurcated into blood testing, genetic testing, pre-implantation genetic diagnosis (PGD), and Others. In 2018, blood testing dominated the diagnosis segment in terms of revenue. The fact that blood testing is extensively used as the tool of first-line screening is a major contributor to its large market share. Due to its efficacy in precise diagnosis and monitoring, genetic testing for sickle cell disease diagnosis is projected to be the fastest-growing segment over the forecast timespan. The end-user segment is segmented into hospitals, diagnostic laboratories, clinics, and other end-user.

Geography-wise, the market is segmented into North America, Europe, Assia Pacific, Latin America, and the Middle East and Africa. Owing to rising R&D investments by key players, a better reimbursement scenario, and the availability of high-quality healthcare services, North America led the overall market in revenue in 2018. The Asia Pacific is expected to experience the fastest growth over the projected period. The launch of indigenously made, low-cost diagnostic kits for thalassemia and sickle cell disease coupled with increasing patient awareness is expected to provide lucrative growth opportunities for manufacturers in the near future.

Top key players operating in the market are Alnylam Pharmaceuticals, bluebird bio Inc., Celgene Corporation, Emmaus Life Sciences Inc., Gamida Cell, Global Blood Therapeutics, Prolong Pharmaceuticals, Sangamo, Therapeutics Inc., Sanofi amongst others.

This report segments the Global Hemoglobinopathies Market as follows:

Global Hemoglobinopathies Market: Indication Segment Analysis

  • Sickle cell disease
  • Alpha Thalassemia
  • Beta Thalassemia
  • Others

Global Hemoglobinopathies Market: Therapy Segment Analysis

  • Blood Transfusion
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others

Global Hemoglobinopathies Market: Diagnosis Segment Analysis

  • Blood testing
  • Genetic testing
  • Pre-implantation Genetic Diagnosis (PGD)
  • Other

Global Hemoglobinopathies Market: End-user Segment Analysis

  • Hospitals
  • Diagnostic laboratories
  • Clinics
  • Other End-use

Global HemoglobinopathiesMarket: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa

Rest of Middle East & Africa

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
Global Headquarters
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com

Latest Added Market Report

Diagnostic Imaging Services Market by Imaging Modality (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT), Nuclear Imaging, and Others); by Application (Cardiology, Gynecology/Obs, Orthopedics & Musculoskeletal, Oncology, Neurology & Spine, and General Imaging); and by End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the diagnostic imaging services industry. The report analyzes and declares the historical and current trends analysis of the diagnostic imaging services industry and subsequently recommends the projected trends anticipated to be observed in the diagnostic imaging services market during the upcoming years. The <a href="https://www.fnfresearch.com/new ...

Published Date : 21-May-2020 | | Category : Healthcare | Pages : 175 | Format : Read more

Depyrogenated Sterile Empty Vials Market by Product (2 ml, 5 ml, 10 ml, 20 ml, and more than 20 ml) and End-use (Compounding Labs, Clinical Labs, and Pharmaceutical Manufacturers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the dehydrogenated sterile empty vials industry. The report analyzes and declares the historical and current trends analysis of the dehydrogenated sterile empty vials industry and subsequently recommends the projected trends anticipated to be observed in the depyrogenated sterile empty vials market during the upcoming years. The <a href= ...

Published Date : 21-May-2020 | | Category : Healthcare | Pages : 175 | Format : Read more

Complementary and Alternative Medicine Market by Intervention (Acupuncture, Botanicals, Magnetic Intervention, and Body, Mind & Yoga); by Distribution Channel (E-Training, Direct Contact and Distance Correspondence): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the complementary and alternative medicine industry. The report analyzes and declares the historical and current trends analysis of the complementary and alternative medicine industry and subsequently recommends the projected trends anticipated to be observed in the complementary and alternative medicine market during the upcoming years. The <a href ...

Published Date : 21-May-2020 | | Category : Healthcare | Pages : 180 | Format : Read more

Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions